The results showed that FITC-SmANX was as sensitive as FITC-annexin A5 in detecting PS exposure in different apoptotic cells and even better for recognizing a specific mammalian tumor cell line, suggesting that SmANX is promising as a practical tool for detecting early apoptosis in certain cell lines in the future. The gene discussed is ANXA5; the disease is neoplasm.